Search | PALTmed

JAMDA

February 6, 2022

Potential Unintended Consequences of Antipsychotic Reduction in Ontario Nursing Homes

Antipsychotic reduction in nursing homes has been a focus of research and policy attention for several decades; however, there is evidence that these initiatives may have had unintended consequences, such as medication substitution and changes in diagnosis coding. Our objectives were to describe temporal c...

Policy Snapshot

January 21, 2022

CMS Releases Latest Report on Antipsychotic Medication Use

The National Partnership to Improve Dementia Care in Nursing Homes has released its Antipsychotic Medicare Use and Data report for the second quarter of 2021. The Centers for Medicare & Medicaid Services (CMS) is tracking the progress of the National Partnership by reviewing publicly reported measures....

JAMDA

June 2, 2022

Impact of Nursing Home Factors on Antipsychotic Use in Residents Before and After the Implementation of the Antipsychotic Reduction Initiative: A Facility-level Analysis

JAMDA

November 21, 2018

Educating Nursing Home Staff in Dementia Sensitive Communication: Impact on Antipsychotic Medication Use

An educational program to enhance communication in nursing home dementia care increased person-centered communication by staff and resulted in reduced resident behavioral symptoms measured as resistiveness to care. The purpose of this analysis was to evaluate effects on resident antipsychotic medication us...

JAMDA

January 10, 2025

Effects of Nursing Home Changes in Antipsychotic Use on Outcomes among Residents with Dementia

Little information exists on whether nationwide efforts to reduce antipsychotic use among nursing home (NH) residents with Alzheimer's disease and related dementias improved mortality and hospitalization outcomes for residents. Our objective was to examine the effect of NH decreases in antipsychotic u...

JAMDA

June 9, 2020

Policy to Reduce Antipsychotic Use and Hospitalization of Nursing Home Residents With Dementia

Following the 2012 launch of the National Partnership to Improve Dementia Care in Nursing Homes (the National Partnership), the use of antipsychotics has declined. However, little is known about the impact of this effort on quality of care and outcomes for nursing home (NH) residents with Alzheimer's ...

Policy Snapshot

January 20, 2023

CMS to Increase Oversight of Antipsychotics Use

Last week, the U.S. Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), announced new actions to reduce the inappropriate use of antipsychotic medications and to bring greater transparency about nursing home citations to families.

JAMDA

January 5, 2016

Physical Restraint and Antipsychotic Medication Use Among Nursing Home Residents With Dementia

To explore antipsychotic (AP) medications and physical restraint use and their effects on physical function and cognition in older nursing home residents.

JAMDA

February 27, 2016

Antipsychotic Drug Use Is Not Associated With Long-Term Mortality Risk in Norwegian Nursing Home Patients

To assess the long-term mortality risk associated with antipsychotic drug (AP) use in nursing homes.

JAMDA

September 20, 2019

Nursing Home Social Services and Post-Acute Care: Does More Qualified Staff Improve Behavioral Symptoms and Reduce Antipsychotic Drug Use?

An increasing number of post-acute care patients are admitted to skilled nursing facilities (SNFs) with behavioral symptoms such as wandering and rejecting care, which can interfere with care and place a patient at risk of social isolation or injury. This study examines whether increasing the qualification...